SOF/VEL FOR 12 WEEKS RESULTS IN HIGH SVR12 RATES IN SUBJECTS WITH NEGATIVE PREDICTORS OF RESPONSE TO TREATMENT: AN INTEGRATED ANALYSIS OF EFFICACY FROM THE ASTRAL-1, ASTRAL-2 AND ASTRAL-3 STUDIES

被引:3
作者
Agarwal, K. [1 ]
Patel, K. [2 ]
Samuel, D. [3 ]
Bourliere, M. [4 ]
Younes, Z. [5 ]
Morgan, T. [6 ]
Strasser, S. [7 ]
Leggett, B. [8 ]
Liu, L. [9 ]
Ding, X. [9 ]
McNally, J. [9 ]
Osinusi, A. [9 ]
Brainard, D. [9 ]
Subramanian, M. [9 ]
Afdhal, N. [10 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, London, England
[2] Univ Hlth Network Liver Clin, Toronto, ON, Canada
[3] Ctr Hepatobiliaire, Villejuif, France
[4] Hop St Joseph, Marseille, France
[5] GastroOne, Germantown, MD USA
[6] VA Long Beach, Long Beach, CA USA
[7] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
[8] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[9] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
10.1016/S0168-8278(16)01535-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-195
引用
收藏
页码:S787 / S788
页数:2
相关论文
empty
未找到相关数据